Insmed Incorporated (1INSM)
MTA
Real-time Data
07:00 AM
Day's Range
103.8052 wk Range
79.25Overview - 1INSM - Insmed Incorporated
Key Statistics
Valuation
Enterprise Value
19.20B
P/E (Trailing)
‪-16.16‬
PEG Ratio
‪0.16‬
Price / Sales (TTM)
‪19.61‬
Price / Book
‪33.51‬
EV / EBITDA
‪-27.54‬
Profitability
Gross Margin
‪84.20%‬
Profit Margin
‪-76.94%‬
Operating Margin
‪-23.80%‬
Return on Assets
‪-22.16%‬
Return on Equity
‪-87.21%‬
Ownership
Shares Outstanding
218.28M
Float
216.93M
Held by Insiders
‪0.50%‬
Held by Institutions
‪105.00%‬
Price stats
Beta
‪0.81‬
50-Day Avg
‪104.24‬
200-Day Avg
‪114.56‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - 1INSM - Insmed Incorporated
Peers - 1INSM - Insmed Incorporated
Peer Comparison
Compared with companies in Biotechnology listed on MTA.
- 1INSMMTAInsmed Incorporated30.28BMarket Cap-19.46%52-week change-16.17P/E (Trailing)‪-76.94%‬Profit Margin
- 1VRTXMTAVertex Pharmaceuticals Incorporated Common Stock107.27BMarket Cap+27.72%52-week change30.40P/E (Trailing)‪34.99%‬Profit Margin
- 1REGNMTARegeneron Pharmaceuticals, Inc.73.52BMarket Cap+30.66%52-week change19.47P/E (Trailing)‪27.86%‬Profit Margin
- 1ALNYMTAAlnylam Pharmaceuticals, Inc.45.81BMarket Cap-73.35%52-week change43.84P/E (Trailing)‪16.12%‬Profit Margin
- 1CGMTAThe Carlyle Group Inc.18.64BMarket Cap-40.10%52-week change42.38P/E (Trailing)‪13.01%‬Profit Margin
- 1INCYMTAIncyte Corp.17.89BMarket Cap+32.92%52-week change15.77P/E (Trailing)‪27.70%‬Profit Margin
- 1RVMDMTARevolution Medicines, Inc.12.75BMarket Cap+72.89%52-week change-28.65P/E (Trailing)‪0.00%‬Profit Margin
Profile Summary - 1INSM - Insmed Incorporated
About
Insmed Inc. is a global biopharmaceutical company focused on developing and commercializing therapies for patients with serious and rare diseases. The company concentrates its activities across three key therapeutic areas: respiratory, immunology and inflammation, and neuro and other rare conditions. Insmed’s…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
